Cephalon Company Description
Cephalon isn't asleep at the wheel. The company sells PROVIGIL, a treatment for the sleep disorder narcolepsy, in the US and select countries around the world. The company's other top sellers are cancer pain medications ACTIQ and FENTORA, epilepsy treatment GABITRIL (licensed from Abbott Labs and Novo Nordisk), and cancer drug TREANDA. It sells seven products in the US and has more than a dozen approved drugs on the market in Europe. Cephalon's drug research and development activities focus on central nervous system disorders, cancer, and pain.
View the Comprehensive Company Description for Cephalon
The Company Description provides a historical perspective of Cephalon's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Cephalon's evolution in the marketplace.
